HVTN 069

A Phase Ib Clinical Trial to Compare the Safety, Tolerability, and Immunogenicity of an HIV-1 Adenoviral Vector Boost Administered Intramuscularly, Intradermally, or Subcutaneously After an HIV-1 DNA Plasmid Vaccine Prime Administered Intramuscularly

Trial Details:

Ib Completed
HVTN, National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) November 29, 2006
VRC-HIVADV014-00-VP,VRC-HIVDNA009-00-VP DNA gag B, gol B, nef B, env A, env B, env C ; Ad5 Gag-Pol Env A/B/C
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA 90